Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 13/20 | 0.61 |
| ▸ | PPARG | P37231 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.48 |
| ▸ | EGFR | P00533 | 1/20 | 0.47 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7896098 | 1.00 | NFE2L2 (0.61) | NFE2L2PPARGMEN1ALDH1A1KMT2A | |
| SCHEMBL1195311 | 0.93 | NFE2L2 (0.57) | NFE2L2PPARGTLR9EGFR | |
| SCHEMBL1195313 | 0.93 | NFE2L2 (0.57) | NFE2L2PPARGTLR9EGFR | |
| SCHEMBL1194466 | 0.90 | NFE2L2 (0.61) | NFE2L2ALDH1A1 | |
| SCHEMBL1194462 | 0.90 | NFE2L2 (0.61) | NFE2L2ALDH1A1 | |
| SCHEMBL5572462 | 0.86 | TLR9 (0.64) | NFE2L2PPARGALDH1A1KMT2ATLR9 | |
| SCHEMBL5572469 | 0.86 | TLR9 (0.64) | NFE2L2PPARGALDH1A1KMT2ATLR9 | |
| SCHEMBL29149692 | 0.86 | TLR9 (0.64) | NFE2L2PPARGALDH1A1KMT2ATLR9 | |
| SCHEMBL15497047 | 0.82 | TLR9 (0.60) | NFE2L2MEN1ALDH1A1KMT2ATLR9 | |
| SCHEMBL1194083 | 0.82 | NFE2L2 (0.63) | NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117430125-B | Preparation method and application of manganese doped mesoporous structure-containing acidic Beta zeolite molecular sieve | 常州大学 | 2025-03-21 | — | — | CN | disclosed |
| CN-117430125-A | Preparation method and application of manganese doped mesoporous structure-containing acidic Beta zeolite molecular sieve | 常州大学 | 2024-01-23 | — | — | CN | disclosed |
| US-20210207175-A1 | COMPOUND FOR REGULATING GENE EDITING EFFICIENCY AND APPLICATION THEREOF | SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) | 2021-07-08 | — | — | US | disclosed |
| CN-109096158-B | Preparation method of (E) -alkenyl sulfone compound | 石家庄学院 | 2020-06-12 | — | — | CN | disclosed |
| WO-2019238091-A1 | COMPOUND FOR REGULATING GENE EDITING EFFICIENCY AND APPLICATION THEREOF | 中国科学院上海有机化学研究所 | 2019-12-19 | — | — | WO | disclosed |
| US-6201131-B1 | REACTING A 2-(ARYLSUFONYL) ETHANOL DERIVATIVE WITH AN ACID ANHYDRIDE IN PRESENCE OF A BASE, FURTHER REACTING THIS WITH AN AROMATIC HALIDE IN THE PRESENCE OF A PALLADIUM CATALYST; USEFUL AS INTERMEDIATES TO DRUGS, AGROCHEMICALS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210207175-A1 | COMPOUND FOR REGULATING GENE EDITING EFFICIENCY AND APPLICATION THEREOF | TET2, ZFX, ZFR | NFE2L2 4073/4885PPARG 334/4885MEN1 3647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.